A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF)
Clinical trial NCT05111145 · COMPLETED
Trial details
- NCT number
- NCT05111145
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2022-12-20
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.